196 related articles for article (PubMed ID: 7539523)
1. Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies.
Jackson DM; Mohell N; Georgiev J; Bengtsson A; Larsson LG; Magnusson O; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):146-55. PubMed ID: 7539523
[TBL] [Abstract][Full Text] [Related]
2. Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine.
Jackson DM; Martin LP; Larsson LG; Cox RF; Waszczak BL; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):290-9. PubMed ID: 2126347
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study.
Jackson DM; Ross SB; Larsson LG
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry.
Jones GH; Hernandez TD; Kendall DA; Marsden CA; Robbins TW
Pharmacol Biochem Behav; 1992 Sep; 43(1):17-35. PubMed ID: 1384071
[TBL] [Abstract][Full Text] [Related]
5. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
Walters DE; Howard SG
Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
[TBL] [Abstract][Full Text] [Related]
6. [Effects of ethanol and low-carbohydrate diet on contents of noradrenaline, dopamine, serotonin and their metabolites in rat brain].
Hirose T
Nihon Eiseigaku Zasshi; 1991 Aug; 46(3):755-61. PubMed ID: 1720179
[TBL] [Abstract][Full Text] [Related]
7. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
8. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
[TBL] [Abstract][Full Text] [Related]
9. Differential regional and kinetics effects of piribedil and bromocriptine on dopamine metabolites: a brain microdialysis study in freely moving rats.
Pagliari R; Peyrin L; Crambes O
J Neural Transm Gen Sect; 1995; 101(1-3):13-26. PubMed ID: 8695044
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic modulation of serotonin metabolism in rat striatum: a study with dopamine uptake inhibitor GBR-12909.
Sivam SP
Life Sci; 1995; 56(26):PL467-72. PubMed ID: 7540709
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine enhances feeding behavior without changing dopamine metabolism.
Inoue K; Kiriike N; Kurioka M; Fujisaki Y; Iwasaki S; Yamagami S
Pharmacol Biochem Behav; 1997 Sep; 58(1):183-8. PubMed ID: 9264089
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
[TBL] [Abstract][Full Text] [Related]
13. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
Ajima A; Yamaguchi T; Kato T
Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
[TBL] [Abstract][Full Text] [Related]
14. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
[TBL] [Abstract][Full Text] [Related]
15. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
Jackson DM; Ross SB; Hashizume M
Psychopharmacology (Berl); 1988; 94(3):321-7. PubMed ID: 2895938
[TBL] [Abstract][Full Text] [Related]
16. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
Bishop C; Walker PD
Neuroscience; 2003; 121(3):649-57. PubMed ID: 14568025
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
Andrés ME; Gysling K; Bustos G
Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
Santiago M; Rollema H; de Vries JB; Westerink BH
Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
Rouillard C; Bédard PJ; Di Paolo T
Eur J Pharmacol; 1990 Aug; 185(2-3):209-15. PubMed ID: 2253695
[TBL] [Abstract][Full Text] [Related]
20. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
